Generic Amturnide

At this time, a patent prevents a generic Amturnide (aliskiren-amlodipine-hydrochlorothiazide) from being manufactured in the United States. The first patent is expected to expire in July 2018, which would be the earliest date that a generic version might become available. However, certain circumstances could delay this date, such as lawsuits or other patents for new uses of the drug.

Amturnide Drug Information

Can I Buy Generic Amturnide?

Amturnide^® (aliskiren-amlodipine-hydrochlorothiazide) is a prescription medication used to treat high blood pressure (known medically as hypertension). It contains three different blood pressure medications combined in a single tablet.

Amturnide is made by Novartis Pharmaceuticals Corporation. It is currently under the protection of a patent that prevents any generic Amturnide from being manufactured in the United States.

When Will a Generic Version Be Available?

The first patent is set to expire in July 2018. This is the earliest predictable date that a generic version could become available. However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Amturnide uses. Once the patent expires, there may be several companies that manufacture a generic Amturnide drug.

Are There Generic Versions of the Medications in Amturnide?

Amturnide contains three medications:

amlodipine (Norvasc^®), aliskiren (Tekturna^®), and hydrochlorothiazide. While amlodipine and hydrochlorothiazide are available in generic versions, aliskiren is not.

Depending on insurance coverage, it may be less expensive to take Amturnide rather than the three medications separately. It may also be more convenient to take one tablet daily, rather than three.